From law firm to FDA chief-in-waiting: Diamantas defies expectations

TL;DR Summary
Acting FDA commissioner Kyle Diamantas, a former Jones Day attorney with no public-health or government background, has defied early doubts by earning the trust of FDA career staff and signaling a different leadership approach at Marty Makary’s FDA during a period of upheaval.
Reading Insights
Total Reads
0
Unique Readers
14
Time Saved
2 min
vs 3 min read
Condensed
90%
421 → 43 words
Want the full story? Read the original article
Read on statnews.com